Background. Successful breast-conserving surgery requires achieving negative margins. At our institution, the whole surgical specimen is imaged and then serially sectioned with repeat imaging. A multidisciplinary discussion then determines need for excision of additional margins. The goal of this study was to determine the benefit of each component of this approach in reducing the number of positive margin. Methods. This single-institution, prospective study included ten breast surgical oncologists who were surveyed to ascertain whether they would have taken additional margins based their review of whole specimen images (WSI) and review of serially sectioned images (SSI). These results were compared with the multidisciplinary decisions (MDD) and pathology results. Margin status was defined using consensus guidelines. Results. One hundred surveys were completed. Margins on the original specimen were positive or close in 21%. After WSI, surgeons reported that they would have taken additional margins in 26 cases, reducing the number of positive/close margins from 21 to 13% (p \ 0.001). After SSI, 52 would have taken additional margins; however, the number of positive/close margins remained 13%. MDD resulted in additional margins taken in 56 cases, reducing the number of positive/close margins to 7% (p \ 0.001 compared with SSI).
ABSTRACT
Background. Successful breast-conserving surgery requires achieving negative margins. At our institution, the whole surgical specimen is imaged and then serially sectioned with repeat imaging. A multidisciplinary discussion then determines need for excision of additional margins. The goal of this study was to determine the benefit of each component of this approach in reducing the number of positive margin.
Methods. This single-institution, prospective study included ten breast surgical oncologists who were surveyed to ascertain whether they would have taken additional margins based their review of whole specimen images (WSI) and review of serially sectioned images (SSI). These results were compared with the multidisciplinary decisions (MDD) and pathology results. Margin status was defined using consensus guidelines. Results. One hundred surveys were completed. Margins on the original specimen were positive or close in 21%. After WSI, surgeons reported that they would have taken additional margins in 26 cases, reducing the number of positive/close margins from 21 to 13% (p \ 0.001). After SSI, 52 would have taken additional margins; however, the number of positive/close margins remained 13%. MDD resulted in additional margins taken in 56 cases, reducing the number of positive/close margins to 7% (p \ 0.001 compared with SSI).
Conclusions. While surgeon review of specimen radiographs can decrease the number of positive or close margins from 21 to 13%, more rigorous multidisciplinary, intraoperative margin assessment reduces the number of close or positive margins to 7%.
Breast-conserving surgery (BCS) provides equal oncologic outcomes to mastectomy for the management of breast cancer with added benefits of lower operative morbidity and higher patient satisfaction.
1,2 A critical element for successful BCS is achieving negative margins. 3, 4 Patients with positive margins often require a second operation for reexcision, which results in increased costs, patient anxiety, delays in adjuvant therapy, and impacts on cosmetic outcomes. 5, 6 Reoperation rates have been suggested as a quality metric for breast cancer surgery; however, methods to reduce reoperations require added costs. [6] [7] [8] [9] To address this, institutions have introduced heterogeneous approaches to intraoperative assessments of breast specimens. 7, [9] [10] [11] Recently, the American Society of Breast Surgeons convened a consensus conference with the mission ''to reduce the national reoperation rate.'' 12 Their report outlines tools that may reduce the number of positive margin, some of which focus on the intraoperative assessment of surgical specimens.
One recommended approach is for the surgeon to perform and interpret an intraoperative x-ray of the whole specimen to ensure removal of the lesion and localizing clip as well as to determine if additional margins should be taken. 12 However, at our institution intraoperative assessment is performed, which includes a whole specimen radiograph followed by serial sectioning of the specimen with repeat imaging. Images are then reviewed by a multidisciplinary team, including the surgeon, pathologist, and radiologist. This multidisciplinary approach requires increased operating time for specimen processing, pathology support for inking and appropriate sectioning of specimens, and radiology support for interpretation of specimen x-rays. Additionally, because the assessment is made on radiographic and gross evaluation, there is a possibility of removing additional margins, which may be unnecessary. The goal of this study was to determine whether surgeon interpretation alone of specimen imaging differs from that of the multidisciplinary approach currently used.
METHODS
This prospective survey study was performed after Institutional Review Board approval. Surgeons performing BCS for patients with invasive breast cancer or ductal carcinoma in situ (DCIS) were asked to participate in the study during a 4-month period in 2016. Ten surgeons participated completing surveys for a total of 100 cases.
Preoperative localization of nonpalpable breast tumors was performed with needle or I 125 seed localization. Specimens were oriented by the surgeon and then transported to the pathology suite. First, whole specimen imaging (WSI) was performed in the pathology suite. Specimens were then serially sectioned, and these serial sections were imaged (SSI). The radiologist, pathologist, and surgeon reviewed the images together (either in person or by phone) and compared findings to gross examination of the specimen. The surgeon made the final decision to resect additional margins after the MDD based on this multidisciplinary discussion (MDD).
Participating surgeons were asked to complete a survey after reviewing the WSI to indicate if they would anticipate taking additional margins based on their intraoperative findings and WSI. If they indicated that they would anticipate taking additional margins, they were asked which margins they would excise. They were then asked to review the SSI and answer the same questions. Surgeons were required to complete the surveys before discussions with radiology or pathology. The results from the MDD also were recorded. Finally, these results were compared to the surgical pathology report to determine the proportion of patients that would require reexcision based on the surgeon survey and MDD results (Fig. 1 ).
Imaging and pathology reports were reviewed in the electronic health record to record tumor characteristics. Surgical records were reviewed to determine method of localization and whether an oncoplastic procedure (defined as having a plastic surgeon involved in the operation) was performed. Finally, the surgical pathology report was reviewed to assess the volume and margin status of each specimen.
Definition of Margin Status
Margins were classified based on consensus guidelines. 4, 13 For invasive cancer, margins were considered positive if tumor was found on ink. For DCIS with no associated invasive carcinoma or \ 1 mm of invasive disease, margins were positive if DCIS was on ink and close if margins were \ 2 mm. Intraoperative specimen assessment included whole specimen imaging followed by serial sectioning of the specimen with repeat imaging. The pathologist and radiologist review the images and specimen and discuss findings with the surgeon to guide selective removal of additional margins. In this study, surgeons were surveyed after reviewing the whole specimen and serially sectioned images to determine whether they would have taken additional margins based on these findings before discussion with radiology and pathology
Statistical Analysis
Clinicopathologic data was tabulated and surgeon survey results and final pathology results were compared by Fisher's exact test. Tests were two-sided with p values \ 0.05 considered significant. All statistical analyses were performed in SAS (Enterprise Guide 5.1, Cary NC).
RESULTS
Surgeons completed surveys on 100 cases. Tumor size on pre-operative imaging was B 2 cm in 66 cases, 2.1-5 cm in 30, and [ 5 cm in 4 cases. A mass was seen in 81 cases and calcifications (either with or without a mass) were seen in 40. Sixty-five cases had invasive ductal histology (50 of these were associated with DCIS), 25 were pure DCIS, and 10 had lobular histology. Twenty-seven patients received neoadjuvant therapy (either chemotherapy or endocrine). Seventy-four cases used I 125 seed localization, 23 used wire-localization, and 3 used no localization, because they were palpable lesions. Twentysix cases were done as a joint procedure with a plastic surgeon who performed an oncoplastic closure. Table 1 summarizes the clinicopathologic features. Thirteen patients underwent a second operation for reexcision of margins.
Margin Status
The pathologic evaluation of the original surgical specimen (before any additional margins taken) revealed positive or close margins in 21 (21%) patients. After the WSI, surgeons reported that they would have resected an additional margin in 26 cases, which would have reduced the number of positive or close margins to 13% (p \ 0.001). Following review of SSI, surgeons reported they would have taken additional margins in 52 cases. The number of positive or close margins remained the same at 13; however, 2 cases with pure DCIS that had a positive margin were converted to close margins. Finally, the MDD resulted in additional margins being taken in a total of 56 cases, which reduced the proportion of cases with a final positive or close margin to 7% (p \ 0.001 compared with WSI; Table 2 ; Fig. 2 ). In 13 cases, the surgeon considered taking an additional margin after review of images but decided against taking that margin after the MDD. In the 44 cases where no additional margins were taken, none were found to have a positive or close margin on pathology. The positive predictive value of the MDD was 21 of 56 (37.5%), and the negative predictive value was 44 of 44 (100%).
Volume Removed
One concern with removing additional margins is the excess breast volume resected that might impact cosmetic outcomes. We analyzed the volume of breast tissue removed in cases that did not include a plastic surgeon, because this may have impacted the volume removed. The mean volume of breast tissue removed in cases involving a plastic surgeon was 177.4 cm 3 . We also excluded cases from this analysis in which the surgeon reported that they would have taken a margin in their WSI or SSI survey that was not taken after MDD, because the volume of this specific margin could not be determined (n = 13). The mean volume of the original specimen in these remaining 61 cases was 53.3 cm 3 . After evaluation of WSI, surgeons would have removed a mean volume of 55.4 and 57.7 cm 3 after review of SSI. MDD resulted in removal of 59.6 cm 3 .
Variables Impacting Evaluation
Finally, we evaluated features that might impact the surgeons' ability to predict which margins should be removed compared with the MDD, which is summarized in Table 3 . Although we hypothesized that MDD review may be less helpful in cases with a mass on imaging compared with calcifications, this was not the case. In 81 cases with a mass seen on imaging, the proportion of patients with positive or close margins on the original specimen was 
DISCUSSION
Many methods of intraoperative specimen assessment have been utilized in an attempt to decrease reexcision rates after BCS. In this study, we found that removal of a surgical specimen without any intraoperative evaluation of margins would have resulted in positive or close margins in 21% of cases. This was reduced to 13% by surgeons assessing specimen radiographs. Surgeon assessment of serially sectioned images was not superior to evaluation of the whole specimen image. However, adding multidisciplinary evaluation reduced this number to 7%.
Reexcision rates following BCS have been found to be highly variable, ranging from 3 to 50%. 7, 9 Reoperation increases the costs and risks of complications associated with breast cancer surgery. A review of private claims data for 9837 women undergoing BCS showed that 23% underwent at least one additional surgery. The likelihood of a surgical complication was 47% higher with repeated surgery, and the mean 2-year health care costs increased by $11,621 for patients undergoing repeat BCS and $26,276 for those converting to mastectomy. 14 One reason for such variability in reexcision rates is that there has been historical debate defining optimal margins for BCS. In one survey of 418 surgeons performed in 2010, 11% believed that no tumor on ink was adequate, 42% believed that 1-2 mm was required, 28% believed that 5 mm was necessary, and 19% required [ 1 cm. 15 Another survey of 100 surgeons found that 15% would accept any negative margin, 28% a 1-mm margin, 50% would accept 2 mm, 12% would accept 5 mm, and 3% would accept 1 cm. 16 To provide guidance on this issue, consensus guidelines have recently been published based on metaanalyses of available literature. These guidelines specify that no tumor on ink is sufficient in cases of invasive cancer and that a 2-mm margin is optimal in DCIS in patients undergoing BCS with adjuvant radiation. 4, 13 Two studies have shown a 13.6-16% decrease in the number of second operations after BCS for patients with invasive breast cancer after publication of the consensus guidelines. 17, 18 Importantly, these guidelines do not apply to patients who receive neoadjuvant therapy or who do not receive adjuvant radiation.
In an effort to give surgeons methods to reduce the number of patients undergoing reoperation, the American Society of Breast Surgeons convened a consensus conference and published a toolbox of approaches that reduce reoperation rates as well as the data supporting these practices. 12 In this conference, 100% of attendees recommended specimen imaging and surgeon review classifying this as a strong recommendation. We found that surgeon evaluation of the WSI reduced the number of positive/close margins from 21 to 13%. Others have described a similar reduction in the need for reexcision from 31 to 20% with the use of specimen radiography following BCS. 19 In our study, surgeon evaluation of SSI did not reduce the number of positive/close margins compared with the use of WSI. While the reduction from 21 to 13% is clinically significant, the addition of multidisciplinary discussion appears to be the best practice based on our data, because it reduced the number to 7%.
In addition to this toolbox, other institutions have reported methods to reduce the number of positive margins. One study compared the national NSQIP reexcision numbers to reexcision numbers for a single institution using frozen-section analysis. They found that the 30-day reoperation rate was 13.2% nationally compared with 3.6% (p \ 0.001) for the institution using frozen section. 9 Another approach has been routinely to take shave margins or additional margins circumferentially around the tumor bed. In a randomized trial comparing shave margins to selective margin removal, the number of positive margins was significantly lower in the shave margin cohort (19 vs. 34%, p = 0.01) and the number of reoperations was reduced (10 vs. 21%, p = 0.02). 20 However, the total volume of tissue excised was significantly larger in the shave margin group (115.1 vs. 74.2 cm 3 , p \ 0.001). Another randomized trial of patients with ER-negative tumors, found a reduction in positive margins with cavity shave margins (45 vs. 16%, p = 0.005). 21 Our study was not designed to compare our multidisciplinary approach to other methods, although this could be studied in the future.
In this study, we report that 13% of patients ultimately underwent reexcision, whereas only 7% had positive/close margins on final surgical pathology. Multiple factors may have impacted the decision to reexcise. First, 27% of the study cohort had neoadjuvant therapy. For the purpose of this analysis, we defined negative margins as no tumor on ink. However, given the lack of consensus guidelines, some of these patients underwent reexcision to obtain 2-mm margins. In the five patients who received neoadjuvant therapy who underwent reexcision, four had positive margins at their first operation. One had multiple close margins (B 2 mm) even after additional margins were taken, which influenced the decision to reexcise. The second factor that may have impacted the reexcision rate was that this survey was conducted before the publication of the DCIS margin consensus guidelines. In five of the cases, DCIS associated with invasive cancer was \ 2 mm from the final margin. The number of surgeons who decide to reexcise in this scenario may now be reduced, because the consensus guidelines state that DCIS associated with at least 1 mm of invasive carcinoma should be treated according to the invasive guidelines (no tumor on ink). 14 This study is limited by the fact that the survey answers may not accurately predict what would be done in a realworld scenario. It also is a single-institutional study and therefore may not be applicable at other institutions. The multidisciplinary specimen evaluation that we described has been established as a longstanding collaboration at our institution. [22] [23] [24] Other centers may not be able to immediately reproduce the same results. We recognize that this approach requires significant resources that may not be possible in lower-volume centers. We did not evaluate the cost-effectiveness of this approach in the current study; however, this will be important to study in the future.
CONCLUSIONS
We found that an intraoperative specimen evaluation involving a multidisciplinary team of surgeons, pathologists, and radiologists was able to significantly decrease the rate of positive margins in patients undergoing BCS. This collaborative approach increased the number of additional margins taken intraoperatively, but the additional volume resected was minimal.
